Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192345 | SCV000248534 | uncertain significance | not specified | 2015-07-28 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001197987 | SCV001368772 | uncertain significance | Pelizaeus-Merzbacher disease | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Ce |
RCV001311093 | SCV001501136 | uncertain significance | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001331308 | SCV001523325 | uncertain significance | Hereditary spastic paraplegia 2 | 2019-08-12 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |